International Medical Drugs Policy

This graduate paper is aimed at detecting the key points of medical drugs regulation process in scope of international law. To study the issue that was determined above, it is necessary to figure out the following objectives: (a) to perform integrated scientific analysis of present international medical drugs policy; (b) to find out the principal activities of regional intergovernmental organizations, affecting the circulation of medical drugs, on global and regional level; (c) to identify what international legal instruments in the field of medical drugs circulation are usually applied to harmonize regulations; (d) to specify the function of regional organizations in the field of providing access to high quality and safe pharmaceutical products. Based on this research the following conclusions were made: firstly, harmonization of the medicinal products regulations in accordance with international standards improves the efficiency of public health systems, ensures the quality and safety of pharmaceutical products and facilitates its access to the market; secondly, reasonable approach to the adoption of obligations within the World Trade Organization contributes to the development of pharmaceutical industry in the participating countries, and gives competitive advantages for their products; thirdly, pharmaceutical legislation of the European Union created the framework for medical drugs policy harmonization in other regions of the world; fourthly, integration processes that take place within the pharmaceutical market of the Eurasian Economic Union are operated in accordance with the best world standards promote overcoming of import dependence and also guarantee the drug safety for the countries that are members of the Union; fifthly, skill development of staff engaged in the process of pharmaceutical products circulation is needed to provide effective implementation of new regulations in conditions of global harmonization and integration processes.